Evidence map›Paper›PMID 26851394›Full record

ReviewBiomaterials2016

Multifunctional coatings to simultaneously promote osseointegration and prevent infection of orthopaedic implants.

Jordan Raphel, Mark Holodniy, Stuart B Goodman, Sarah C Heilshorn

Abstract readReview
In one paragraph

Review in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jordan RaphelDepartment of Materials Science and Engineering, Stanford University, Stanford, CA, USA.
Mark HolodniyDivision of Infectious Diseases & Geographic Medicine, Stanford University, Stanford, CA, USA; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Stuart B GoodmanDepartment of Orthopaedic Surgery and Bioengineering, Stanford University, Stanford, CA, USA.
Sarah C HeilshornDepartment of Materials Science and Engineering, Stanford University, Stanford, CA, USA. Electronic address: heilshorn@stanford.edu.

Funding

Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R · 2015 to 2025
$13.5M
Engineered Intestinal Microenvironments as Preclinical Drug Screening PlatformsR21EB018407 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2014 to 2015
$427k
3D Bioengineering Strategies to Mimic Human Skeletal Muscle Progenitor Cell NicheR21AR062359 · NIAMS · STANFORD UNIVERSITY · PI BLAU, HELEN M, HEILSHORN, SARAH C · 2011 to 2012
$367k
NIAID NIH HHS U19 AI116484NIAID NIH HHS U19 AI116484-01NIAMS NIH HHS R21 AR062359NIAMS NIH HHS R21 AR062359-01NIBIB NIH HHS R21 EB018407NIBIB NIH HHS R21 EB018407-01
6 · The paper itself

Abstract

The two leading causes of failure for joint arthroplasty prostheses are aseptic loosening and periprosthetic joint infection. With the number of primary and revision joint replacement surgeries on the rise, strategies to mitigate these failure modes have become increasingly important. Much of the recent work in this field has focused on the design of coatings either to prevent infection while ignoring bone mineralization or vice versa, to promote osseointegration while ignoring microbial susceptibility. However, both coating functions are required to achieve long-term success of the implant; therefore, these two modalities must be evaluated in parallel during the development of new orthopaedic coating strategies. In this review, we discuss recent progress and future directions for the design of multifunctional orthopaedic coatings that can inhibit microbial cells while still promoting osseointegration.

Indexed as

AnimalsBacteriaCoated Materials, BiocompatibleHumansJoint ProsthesisOsseointegrationProsthesis FailureProsthesis-Related InfectionsCoated Materials, BiocompatibleAntimicrobial treatmentsFunctional coatingsOrthopaedic implantsOsseointegration

Identifiers

PMID26851394
PMCPMC4883578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.